You searched for "biofilms"

84 results found

Mapping the financial and disease burden of hearing loss and associated interventions

The prevalence and burden of ear and hearing disorders is huge and, historically, has been underappreciated. Globally, unaddressed hearing loss poses a growing public health challenge, requiring urgent attention from policymakers, health professionals and civil society. The recently published World...

Mapping the financial and disease burden of hearing loss and associated interventions

The prevalence and burden of ear and hearing disorders is huge and, historically, has been underappreciated. Globally, unaddressed hearing loss poses a growing public health challenge, requiring urgent attention from policymakers, health professionals and civil society. The recently published World...

When everyday sounds are unbearable: understanding pain and loudness hyperacusis

Everyday sounds can feel unbearably loud or physically painful for people with hyperacusis, a complex disorder that may require tailored, cautious care. Hyperacusis is a disorder in which everyday sounds are experienced as uncomfortable or intolerable. For some people, sounds...

Expanding access to cochlear implants in India: a government-funded journey towards inclusive hearing healthcare

India’s state-funded cochlear implant programmes are transforming hearing care, improving access for children and adults across socioeconomic divides. India boasts a demographic landscape where a substantial portion of its population comprises children, and they play a pivotal role in shaping...

Comparing AutoREM accuracy to NAL-NL2 targets: real patient data and simulator verification

A new study examines how accurately AutoREMs from four major brands hit NAL-NL2 targets, revealing strengths, limits and clinical implications. Automatic real ear measurements (AutoREMs) have emerged as a promising way to make hearing aid fittings faster and more consistent....

Genetic foundations of Ménière’s disease: changing the game

Sydney researchers reveal genetic roots of Ménière’s disease. Familial patterns and gene discoveries highlight autosomal inheritance in rare cases, transforming molecular insights. Ménière’s disease (MD) is a chronic disorder of the inner ear defined by clinical criteria of episodic vertigo...

Worldwide picture of candidacy for cochlear implantation

Who should get a cochlear implant? Candidacy is one of the most important and widely discussed topics in the field of cochlear implantation. Here, Chris Raine and Debi Vickers outline cochlear implant candidacy in the UK, and compare this with...

Access to and uptake of cochlear implants in the UK

Assessing demands on cochlear implant (CI) services is very important for both commissioners and clinicians in anticipating clinical need and funding requirements. Commercial CI’s were introduced in the late 1980s. Initial funding was from charitable sources. The first major advance...

Developing outcome measures for research

There are challenges in developing outcomes measures; Professor Hall presents five top pointers for making rapid progress in developing outcome measures for research purposes. Anyone who has worked clinically with hearing loss will appreciate that every patient’s experience is personal....

Directed audio pointing the way to a great listening experience – HyperSound Clear<sup>TM</sup>

In this Spotlight on Innovation we explore an innovative ultra-thin speaker system compatible with TVs, which can be programmed by a hearing professional to a listener’s hearing profile and preferences to deliver a directed 3D listening experience. Whether your patients...

Underdiagnosing eosinophilic oesophagitis in food bolus obstruction: a wake-up call for ENT units

The management of FBO has evolved, with most cases now done by upper GI clinicians. Biopsies should be taken routinely to investigate possible eosinophilic oesophagitis. In acute soft food bolus obstruction (FBO), uncovering the root cause is as crucial as...

Harnessing head and neck cancer genomics for personalised medicine

Luc Morris updates us on the future of cancer diagnosis and treatment, which lies in “personalised oncology”, where specific molecular alterations of each tumour will be identified, and matched with actionable alterations in existing therapies, ushering in the era of...